Iambic Therapeutics IAM Ratios (2024-2026)

NASDAQ IAM
$14.78 +1.52 (+11.46%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Iambic Therapeutics Quarterly Ratios

Periods 3 quarters
Latest Jun 2026

Iambic Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 3 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2024 Dec2025 Jun2026
Efficiency
Assets AverageAssets Avg. 175.38M216.11M
Equity AverageEquity Avg. -149.41M-209.56M
Invested CapitalInvested Cap. -111.59M-185.89M-231.84M
Leverage & Solvency
Debt Ratio 0.000.000.00

Iambic Therapeutics Ratios API

Pull Iambic Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IAM&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY